Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Chie Onishi"'
Autor:
Naoki Oshima, Yoshiyuki Mishima, Kotaro Shibagaki, Kousaku Kawashima, Norihisa Ishimura, Fumiyoshi Ikejiri, Chie Onishi, Takahiro Okada, Masaya Inoue, Ichiro Moriyama, Junji Suzumiya, Yoshikazu Kinoshita, Shunji Ishihara
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) developed for treatment of patients with chronic myeloid leukemia (CML). The drug has been shown to act as a potent multikinase inhibitor by blocking not only the BC
Externí odkaz:
https://doaj.org/article/852456db15cd41d6b298d2b41507975a
Autor:
Mariko Abe, Louis M Pelus, Pratibha Singh, Tomohiro Hirade, Chie Onishi, Jamiyan Purevsuren, Takeshi Taketani, Seiji Yamaguchi, Seiji Fukuda
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158290 (2016)
Internal tandem duplication (ITD) mutations in the Fms-related tyrosine kinase 3 (FLT3) gene (FLT3-ITD) are associated with poor prognosis in patients with acute myeloid leukemia (AML). Due to the development of drug resistance, few FLT3-ITD inhibito
Externí odkaz:
https://doaj.org/article/40eda58f1ea4428796a81aa963d31a58
Autor:
Chie Onishi, Momoko Nishikori, Kimikazu Yakushijin, Shingo Kurahashi, Hideyuki Nakazawa, Yasushi Takamatsu, Yoshinori Hashimoto, Hiro Tatetsu, null Yuichiro Nawa, Masahiro Yoshida, Tsutomu Kobayashi, Tatsuo Oyake, Shingo Yano, Aki Oride, Ritsuro Suzuki
Publikováno v:
International Journal of Hematology. 115:382-390
This study was conducted to characterize lymphoma occurring during pregnancy and to investigate the outcomes of the patients and the fetuses.Clinical data were gathered retrospectively from 29 patients at 13 participating institutions, and data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca2cc0cf29dab5a132f416c9813c10f
https://doi.org/10.1007/s12185-021-03281-w
https://doi.org/10.1007/s12185-021-03281-w
Publikováno v:
Journal of Food System Research. 28:256-261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0051cd50345228ced9be67549bb24f48
https://doi.org/10.5874/jfsr.21_00037
https://doi.org/10.5874/jfsr.21_00037
Autor:
Seiji, Fukuda, Nozomi, Matsuda, Tsukimi, Shoji, Chie, Onishi, Tomohiro, Hirade, Takeshi, Taketani, Louis M, Pelus
Publikováno v:
Leukemia research. 124
CXCR4 antagonists sensitize FLT3/ITD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::549015893240d67e10114d64b5382474
https://pubmed.ncbi.nlm.nih.gov/36473282
https://pubmed.ncbi.nlm.nih.gov/36473282
Autor:
Seiji Fukuda, Nozomi Matsuda, Tsukimi Shoji, Chie Onishi, Tomohiro Hirade, Takeshi Taketani, Louis M. Pelus
Publikováno v:
Leukemia Research. 124:106983
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60e767e0e3848a806f7aa7c75dac0472
https://doi.org/10.1016/j.leukres.2022.106983
https://doi.org/10.1016/j.leukres.2022.106983
Autor:
Tsutomu, Takahashi, Fumimasa, Takahashi, Yusuke, Okada, Shunsuke, Ito, Norimi, Ugata, Yasumasa, Shimasaki, Hiroshi, Mochida, Shinichiro, Matsuda, Takahiro, Okada, Satoshi, Kumanomidou, Yumi, Jo, Koji, Adachi, Fumiyoshi, Ikejiri, Chie, Onishi, Koshi, Kawakami, Ichiro, Moriyama, Masaya, Inoue, Takaaki, Miyake, Ritsuro, Suzuki, Junji, Suzumiya
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(3)
Prophylactic granulocyte-colony stimulating factor(G-CSF)is necessary for some cancer patients receiving anti-cancer drugs. However, it is difficult for cancer patients in rural areas to receive G-CSF as outpatients because of inconvenient official t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3eace477440b63bd0410f02fb0cca447
https://pubmed.ncbi.nlm.nih.gov/30914584
https://pubmed.ncbi.nlm.nih.gov/30914584
Publikováno v:
Internal Medicine. 54:737-742
Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect of some anti-cancer drugs. However, medical staff frequently encounter difficulties in ascertaining the severity of CIPN. We sought to develop a question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15b87b2cab0ba00846e8ffa274fbc22
https://doi.org/10.2169/internalmedicine.54.3318
https://doi.org/10.2169/internalmedicine.54.3318
Publikováno v:
Blood. 134:2558-2558
The Runx1 transcriptional factor is significantly elevated in human AML cells with FLT3/ITD mutations (Behrens et al. JEM 2017) and enhances the resistance of FLT3/ITD+ 32D cells to the type II FLT3 inhibitor quizartinib (Hirade et al. IJH 2016). Whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::945f8f05ee9fb55641680cc31600df15
https://doi.org/10.1182/blood-2019-129513
https://doi.org/10.1182/blood-2019-129513